GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: IONIS-FXI-LRx
Compound class:
Nucleic acid
Comment: Fesomersen (IONIS-FXI-LRx) is a conjugated antisense oligonucleotide that selectively inhibits the expression of factor XI [1]. It is being explored as an anticoagulation therapy.
We provide the basic nucleotide sequence, without the modifications outlined in the INN record for this drug. |
Classification ![]() |
|
| Compound class | Nucleic acid |
| Compound subclass | Antisense oligonucleotide (ASO) |
| Target | Factor XI |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 11638 | fesomersen |
Synonyms ![]() |
| IONIS-FXI-LRx |
Database Links ![]() |
|
| CAS Registry No. | 2380135-03-3 (source: WHO INN record) |
| GtoPdb PubChem SID | 518520708 |
| Search PubMed clinical trials | fesomersen |
| Search PubMed titles | fesomersen |
| Search PubMed titles/abstracts | fesomersen |